Literature DB >> 16300636

Enhanced episodic-like memory and kindling epilepsy in a rat model of tuberous sclerosis.

Robert Waltereit1, Hans Welzl, Johannes Dichgans, Hans-Peter Lipp, Werner J Schmidt, Michael Weller.   

Abstract

Tuberous sclerosis complex (TSC) is a common neurological autosomal-dominant syndrome caused by mutations in the TSC1 or TSC2 genes. TSC starts in early childhood and is characterized by cerebral hamartomas (benign tumours), severe epilepsy and cognitive deficits such as mental retardation and autism. The hamartomas are characterized by loss of the remaining wild-type TSC allele, and clinical data implicate cerebral hamartomas in the generation of epileptic seizures, which may play a significant role in the development of mental retardation. The TSC2 mutation predicts alterations in mitogen-associated protein kinase (MAPK) and, together with the TSC1 mutation, in mammalian target of rapamycin (mTOR) signalling pathways. Both pathways are involved in neuronal plasticity. We therefore hypothesized that the heterozygous mutation itself, besides cerebral hamartomas, contributes to the pathogenesis of cognitive deficits and possibly also epilepsy. Here, we show that young adult TSC2+/- rats, which are virtually free of cerebral hamartomas, exhibit enhanced episodic-like memory and enhanced responses to chemically-induced kindling. The activation of cyclic adenosine monophosphate (cAMP) in the hippocampus results in stronger induction of phospho-p42-MAPK in TSC2+/- rats than in wild-type animals. Thus, the cognitive phenotype and, possibly, epilepsy in TSC patients may result not only from the focal hamartomatous lesions but also, from altered neuronal plasticity in the heterozygous tissue.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16300636     DOI: 10.1111/j.1471-4159.2005.03538.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  34 in total

1.  Is cognition altered in the eker rat model of tuberous sclerosis complex?

Authors:  Carl E Stafstrom
Journal:  Epilepsy Curr       Date:  2006 Nov-Dec       Impact factor: 7.500

Review 2.  Mechanisms of epileptogenesis in tuberous sclerosis complex and related malformations of cortical development with abnormal glioneuronal proliferation.

Authors:  Michael Wong
Journal:  Epilepsia       Date:  2007-08-28       Impact factor: 5.864

Review 3.  mTOR activation is a biomarker and a central pathway to autoimmune disorders, cancer, obesity, and aging.

Authors:  Andras Perl
Journal:  Ann N Y Acad Sci       Date:  2015-04-23       Impact factor: 5.691

4.  Genetic activation of mTORC1 signaling worsens neurocognitive outcome after traumatic brain injury.

Authors:  Natalia S Rozas; John B Redell; Julia L Hill; James McKenna; Anthony N Moore; Michael J Gambello; Pramod K Dash
Journal:  J Neurotrauma       Date:  2014-12-10       Impact factor: 5.269

5.  NitroSynapsin for the treatment of neurological manifestations of tuberous sclerosis complex in a rodent model.

Authors:  Shu-Ichi Okamoto; Olga Prikhodko; Juan Pina-Crespo; Anthony Adame; Scott R McKercher; Laurence M Brill; Nobuki Nakanishi; Chang-Ki Oh; Tomohiro Nakamura; Eliezer Masliah; Stuart A Lipton
Journal:  Neurobiol Dis       Date:  2019-03-27       Impact factor: 5.996

6.  A Critical Kinase Cascade in Neurological Disorders: PI 3-K, Akt, and mTOR.

Authors:  Zhao Zhong Chong; Yan Chen Shang; Shaohui Wang; Kenneth Maiese
Journal:  Future Neurol       Date:  2012-11

7.  Irradiation exacerbates cortical cytopathology in the Eker rat model of tuberous sclerosis complex, but does not induce hyperexcitability.

Authors:  Naranzogt Tschuluun; H Jürgen Wenzel; Philip A Schwartzkroin
Journal:  Epilepsy Res       Date:  2006-09-29       Impact factor: 3.045

Review 8.  Genetic animal models of malformations of cortical development and epilepsy.

Authors:  Michael Wong; Steven N Roper
Journal:  J Neurosci Methods       Date:  2015-04-21       Impact factor: 2.390

9.  Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis.

Authors:  Dan Ehninger; Sangyeul Han; Carrie Shilyansky; Yu Zhou; Weidong Li; David J Kwiatkowski; Vijaya Ramesh; Alcino J Silva
Journal:  Nat Med       Date:  2008-06-22       Impact factor: 53.440

Review 10.  A circuitry and biochemical basis for tuberous sclerosis symptoms: from epilepsy to neurocognitive deficits.

Authors:  David M Feliciano; Tiffany V Lin; Nathaniel W Hartman; Christopher M Bartley; Cathryn Kubera; Lawrence Hsieh; Carlos Lafourcade; Rachel A O'Keefe; Angelique Bordey
Journal:  Int J Dev Neurosci       Date:  2013-02-26       Impact factor: 2.457

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.